Sensei Biotherapeutics (SNSE) Announces CFO Resignation

On March 27, 2024, Erin Colgan notified Sensei Biotherapeutics (NASDAQ: SNSE) of her resignation from all positions with the Company, including as Chief Financial Officer. Ms. Colgan’s resignation is voluntary and will be effective April 10, 2024, and was not related to any disagreement with the Company on any matter relating to the Company’s operations, policies or practices.

You May Also Be Interested In

• GoPro promotes CFO Brian Tratt to senior vice president role
• Vision Marine and Avikus begin electric boat navigation integration
• CXApp acquires Australian firm EngineRoom in June 2026 deal